Ketogenic diet can boost efficacy of pancreatic cancer therapy

A study of fasting and the ketogenic diet reveals a new vulnerability of pancreatic tumors to an existing cancer drug.

Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target

BARCELONA, Spain — A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a type of

September 14, 2024

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

LOUISVILLE, Ky. — Large tumor size and high disease grade were associated with an increased risk of early cancer-related death in patients with high-risk, non-metastatic

November 13, 2024

A call for robust H5N1 influenza preparedness and response

As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.